Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases

Area of Science:

• Pharmacology and Nanotechnology
• Cardiovascular Medicine
• Drug Delivery Systems

Background:

• Cardiovascular diseases (CVD) are a major global health burden.
• Curcumin (CUR) exhibits therapeutic potential for CVD, including anti-hypercholesterolemic, anti-atherosclerotic, and cardioprotective effects.
• Poor bioavailability limits curcumin's clinical application.

Purpose of the Study:

• To review nanotechnology-based drug delivery systems for curcumin in CVD treatment.
• To discuss formulation properties, experimental evidence, and bioactivity of these systems.
• To identify challenges and opportunities in developing nanomedicine for CVD.

Main Methods:

• Literature review of pre-clinical and clinical studies.
• Analysis of various nanotechnology-based curcumin formulations.
• Evaluation of experimental data on efficacy and safety.

Main Results:

• Nanotechnology significantly improves curcumin's bioavailability and therapeutic efficacy in CVD models.
• Formulation strategies like nanoparticles, liposomes, and micelles enhance curcumin delivery.
• Evidence supports curcumin's role in managing hypercholesterolemia, atherosclerosis, and ischemia-reperfusion injury.

Conclusions:

• Nanotechnology-based curcumin delivery systems offer a promising therapeutic strategy for cardiovascular diseases.
• Further research is needed to optimize formulations and address challenges for clinical translation.
• These advanced systems hold potential to overcome curcumin's bioavailability limitations in CVD treatment.